诊断学理论与实践2024，Vol.23Issue(2)：119-125,7.DOI:10.16150/j.1671-2870.2024.02.004
2023年小肠疾病诊治进展
Advances in study on the diagnosis and treatment of small intestinal diseases in 2023
摘要
Abstract
In 2023,multiple important discoveries and breakthroughs have been made in the field of small intestine diseases,and database-based global epidemiological study on small intestinal cancer was first released.It showed that the global incidence rate of small intestinal cancer in 2020 was 0.6/100 000,which was on an upward trend compared with the average incidence rate from 2010 to 2020(average annual change percentage in different continents,2.20%to 21.67%).The burden of small intestinal cancer was geographic disparity,and age-standardized incidence rate(1.4/100 000)was high-est in North America.The incidence rate of small intestinal cancer in China was 0.32/100 000 for men and 1.95/100 000 for women.Risk factors for small bowel cancer(β=0.008 to 0.198;OR=1.07 to 10.01)included higher human develop-ment index and gross domestic product;smoking and drinking habits;lack of exercise,obesity,diabetes,and lipid metabo-lism disorders;history of inflammatory bowel diseases.Therapeutically,the combined use of sulindac and erlotinib has been effective in reducing the polyp burden in patients with familial adenomatous polyposis.For Crohn's disease in the small intestine,in terms of software,AI-assisted endoscopic recognition has been proven to reduce misdiagnosis,improving medical quality.In terms of hardware,the electric spiral enteroscopy is a double-edged sword.Although it has a higher rate of completing entire small intestine examination,it cannot be widely used in clinical practice until its safety is fully guaran-teed.In terms of drugs,with the in-depth understanding of the pathogenesis of the disease,targeted therapy for the inflam-matory process has gradually become a research hotspot.Clinical data on small-molecule agents such as upadacitinib and filgotinib are continuously accumulating.In terms of surgery,the latest evidence supports that surgery may become a first-line treatment for specific Crohn's disease.The diagnosis and treatment of small intestine bleeding are also continuously improving.Thalidomide,as a drug used to treat small intestine bleeding caused by capillary malformations,has brought good news to a large number of patients.In addition,the surgical treatment for small intestine obstruction is gradually being updated,and there are now more accurate prediction models for treatment decisions in patients with small intestine obstruction.Looking ahead,with the continuous development and innovation of medical technology,and artificial intelligence,the diagnosis and treatment of small intestinal diseases will become more precise and efficient.关键词
小肠疾病/内镜/小肠出血Key words
Small intestinal diseases/Enteroscopy/Small intestine bleeding分类
医药卫生引用本文复制引用
张硕文,顾于蓓..2023年小肠疾病诊治进展[J].诊断学理论与实践,2024,23(2):119-125,7.基金项目
国家重点研发项目资助(2023YFC2507300) （2023YFC2507300）
国家自然科学基金(82000494) （82000494）
爱在延长炎症性肠病基金会青峰科研资助项目资助(CCCF-QF-2023B46-27) （CCCF-QF-2023B46-27）
